In this episode, Colleen discusses how preparing for CAR T-cell therapy reinforced the importance of asking questions, understanding every available treatment option, and advocating for care that aligned with her values. Drawing on both her professional background and personal experience, she shares practical advice for patients on becoming active partners in treatment decisions and embracing the hope that scientific advances continue to bring.

In this episode, Colleen shares how a routine physical led to her diagnosis of smoldering multiple myeloma and reflects on the treatment decisions, clinical trials, second opinions, and personalized care that shaped her path toward CAR T-cell therapy. She discusses why seeking a specialist, exploring clinical trials, and weighing every option against her personal goals and responsibilities helped her confidently navigate the years leading up to relapse.

Dina Ioffe, MD, discusses the importance of liver function in the treatment of unresectable hepatocellular carcinoma. She also explores data from the HIMALAYA trial on 5-year overall survival outcomes by liver function with durvalumab plus tremelimumab treatment.

In this episode, multiple myeloma survivor Otis and his wife and care partner, Tracy, share the many facets of their multiple myeloma journey. They discuss how they kept loved ones informed without becoming overwhelmed, Otis’s experience with CAR T therapy, and the ways their relationship has grown stronger through every stage of the treatment journey.

In this episode, multiple myeloma survivor Otis and his wife and care partner Tracy share their path from a delayed diagnosis to CAR T therapy and remission, highlighting the power of self-advocacy and informed decision-making. Together, they explore the critical role of care partners, the importance of building a strong support network, and how asking for help can be life-changing for both patients and care partners.

Andy, who was diagnosed with multiple myeloma in 2013 and frequently mentors newly diagnosed individuals with multiple myeloma, shares common advice that he provides to his mentees for taking control of their journey. 

Andy, who was diagnosed with multiple myeloma in 2013, shares his experience as a mentor to newly diagnosed individuals with multiple myeloma

Donna, who was diagnosed with multiple myeloma in 2012 and underwent CAR-T therapy in 2023, shares her strategies for caring for her mental health and maintaining a positive outlook, and how her CAR-T treatment success has contributed to the rediscovery of joy in her life. 

Donna, who was diagnosed with multiple myeloma in 2012 and underwent CAR-T therapy in 2023, shares her love of physical fitness and how consistent activity has helped her to maintain independence, motivation, and a zest for life as she navigates her myeloma journey. 

Tony, who was diagnosed with multiple myeloma in 2013, discusses his emotional journey as he processes his CAR-T therapy success with his oncologist, Dr. Peter Voorhees.